Statin Use and Risks of Influenza-Related Outcomes Among Older Adults Receiving Standard-Dose or High-Dose Influenza Vaccines Through Medicare During 2010–2015 | Zendy

Héctor S. Izurieta | Zendy; Yoganand Chillarige | Zendy; Jeffrey A. Kelman | Zendy; Richard A. Forshee | Zendy; Yandong Qiang | Zendy; Michael Wernecke | Zendy; Jill M. Ferdinands | Zendy; Yun Lu | Zendy; Yuqin Wei | Zendy; Wenjie Xu | Zendy; Michael Lu | Zendy; Alicia M. Fry | Zendy; Douglas Pratt | Zendy; David K. Shay | Zendy

Open Access

Statin Use and Risks of Influenza-Related Outcomes Among Older Adults Receiving Standard-Dose or High-Dose Influenza Vaccines Through Medicare During 2010–2015

Author(s) -

Héctor S. Izurieta,

Yoganand Chillarige,

Jeffrey A. Kelman,

Richard A. Forshee,

Yandong Qiang,

Michael Wernecke,

Jill M. Ferdinands,

Yun Lu,

Yuqin Wei,

Wenjie Xu,

Michael Lu,

Alicia M. Fry,

Douglas Pratt,

David K. Shay

Publication year - 2018

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciy100

Subject(s) - medicine , confidence interval , statin , retrospective cohort study , poisson regression , emergency medicine , relative risk , influenza vaccine , cohort study , vaccination , environmental health , immunology , population

Statins are used to reduce cardiovascular disease risk. Recent studies suggest that statin use may be associated with an increased influenza risk among influenza vaccinees. We used Medicare data to evaluate associations between statins and risks of influenza-related encounters among vaccinees.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research